Suppr超能文献

构建一种具有诱导性、心肌细胞特异性过表达PPAR β/δ的转基因小鼠模型。

Generation of an inducible, cardiomyocyte-specific transgenic mouse model with PPAR β/δ overexpression.

作者信息

Kim Teayoun, Zhelyabovska Olga, Liu Jian, Yang Qinglin

机构信息

Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

Methods Mol Biol. 2013;952:57-65. doi: 10.1007/978-1-62703-155-4_4.

Abstract

Peroxisome proliferator-activated receptors (PPARs) consist of three subtypes, each displaying distinctive tissue distribution. In general, the three PPAR subtypes exert overlapping function in transcriptional regulation of lipid metabolism. However, each PPAR subtype possesses distinctive functions in different tissues dependent on their expression abundance, endogenous ligands, and the PPAR coregulators in a specific tissue. Transgenesis is an invaluable technique in defining the in vivo function of a particular gene and its protein. Cre/LoxP-mediated gene targeting has been extensively used to explore the tissue-specific function of PPARs. While this tissue-specific loss-of-function approach is extremely useful in determining the essential role of a PPAR, the tissue-specific gain-of-function approach is another important technique used to understand the effects of PPAR activation in a particular tissue. Transgenic overexpression of PPAR in a specific tissue has been used. However, this conventional technique requires generating the transgenic models individually for each target tissue. In this chapter, we describe the methodology for a more efficient generation of transgenic mouse models with a constitutively active form of PPARβ/δ in different tissues.

摘要

过氧化物酶体增殖物激活受体(PPARs)由三种亚型组成,每种亚型都有独特的组织分布。一般来说,这三种PPAR亚型在脂质代谢的转录调控中发挥重叠作用。然而,每种PPAR亚型在不同组织中具有独特功能,这取决于它们在特定组织中的表达丰度、内源性配体以及PPAR共调节因子。转基因技术是确定特定基因及其蛋白质体内功能的一项重要技术。Cre/LoxP介导的基因靶向已被广泛用于探索PPARs的组织特异性功能。虽然这种组织特异性功能缺失方法在确定PPAR的重要作用方面极为有用,但组织特异性功能获得方法是另一种用于了解PPAR激活在特定组织中作用的重要技术。已采用在特定组织中转基因过表达PPAR的方法。然而,这种传统技术需要为每个靶组织分别生成转基因模型。在本章中,我们描述了在不同组织中更高效地生成具有组成型活性形式PPARβ/δ的转基因小鼠模型的方法。

相似文献

3
Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
Expert Opin Ther Targets. 2005 Aug;9(4):861-73. doi: 10.1517/14728222.9.4.861.
7
Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice.
Biochem Biophys Res Commun. 2008 Jul 4;371(3):456-61. doi: 10.1016/j.bbrc.2008.04.086. Epub 2008 Apr 28.
8
Endothelial, but not smooth muscle, peroxisome proliferator-activated receptor β/δ regulates vascular permeability and anaphylaxis.
J Allergy Clin Immunol. 2015 Jun;135(6):1625-35.e5. doi: 10.1016/j.jaci.2014.11.006. Epub 2014 Dec 31.
9
Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination.
FASEB J. 2003 Apr;17(6):749-51. doi: 10.1096/fj.02-0438fje. Epub 2003 Feb 19.
10
PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation.
FASEB J. 2004 Sep;18(12):1477-9. doi: 10.1096/fj.04-1944fje. Epub 2004 Jul 9.

引用本文的文献

2
ATP synthase inhibitory factor subunit 1 regulates islet β-cell function via repression of mitochondrial homeostasis.
Lab Invest. 2022 Jan;102(1):69-79. doi: 10.1038/s41374-021-00670-x. Epub 2021 Oct 4.
3
High-fat diet activates a PPAR-δ program to enhance intestinal stem cell function.
Cell Stem Cell. 2021 Apr 1;28(4):598-599. doi: 10.1016/j.stem.2021.03.001.
4
RUNX1: an emerging therapeutic target for cardiovascular disease.
Cardiovasc Res. 2020 Jul 1;116(8):1410-1423. doi: 10.1093/cvr/cvaa034.
5
Hepatic PKA inhibition accelerates the lipid accumulation in liver.
Nutr Metab (Lond). 2019 Oct 11;16:69. doi: 10.1186/s12986-019-0400-5. eCollection 2019.
6
Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair.
Cell Res. 2017 Aug;27(8):1002-1019. doi: 10.1038/cr.2017.84. Epub 2017 Jun 16.
7
Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor-γ Disrupts Vascular Wall Structure and Function.
PLoS One. 2015 Oct 9;10(10):e0139756. doi: 10.1371/journal.pone.0139756. eCollection 2015.
8
Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.
Nucl Recept Signal. 2015 Apr 27;13:e001. doi: 10.1621/nrs.13001. eCollection 2015.

本文引用的文献

2
PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization.
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22504-9. doi: 10.1073/pnas.0912487106. Epub 2009 Dec 16.
3
Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.
Transgenic Res. 2010 Aug;19(4):715-25. doi: 10.1007/s11248-009-9342-4. Epub 2009 Nov 6.
4
Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.
Circ Res. 2009 Jul 2;105(1):12-5. doi: 10.1161/CIRCRESAHA.109.198416. Epub 2009 Jun 11.
6
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21.
7
Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase.
J Card Fail. 2006 Jun;12(5):392-8. doi: 10.1016/j.cardfail.2006.03.002.
8
PPAR gamma signaling exacerbates mammary gland tumor development.
Genes Dev. 2004 Mar 1;18(5):528-40. doi: 10.1101/gad.1167804.
10
Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
Dev Biol. 2001 Feb 15;230(2):230-42. doi: 10.1006/dbio.2000.0106.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验